Coronvirus treatment: Plitidepsin, according to the researchers, should be considered for clinical trials based on its in vivo study results. Plitidepsin aka Aplidin is owned by Spanish pharmaceutical company Pharma Mar

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

The U.S. drugmaker plans to enrol up to 30,000 participants for the study and run it in parallel with a one-dose trial with as many as 60,000 volunteers that began in September

Dexamethasone and other steroids are prescribed to treat cytokine storms, they said these drugs can backfire in patients whose immune response is already suppressed

University of Washington's Institute for Health Metrics and Evaluation said it had been using an infection-fatality rate (IFR) derived from surveys after accounting for age

Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients

Subsequently, Trump received barrage of criticism from the medical community with a protocol-breaking visit to his supporters outside the hospital

WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids

Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical

Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv

WHO is working to ensure fair vaccine distribution, but in the meantime it is key to suppress the virus's spread, said Mike Ryan, head of WHO's emergencies program, as daily new cases around the globe are at near-record levels.

In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic

For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers

A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support

Google's June trend search report showed some interesting insights. Post the death of actor Sushant Singh Rajput on June 14, the late actor was the top trending topic across India

In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September

The 250,000 treatment courses that the company had donated to the US and other countries will run out in about a week, and the prices will apply to the drug after that

While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough

Lockdown in Maharashtra: The Chief Minister, in his address to the public, also stated that there is no place for the word 'lockdown' but we have to take our steps carefully

\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"